Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Current Assets: 2017-2020

Historic Current Assets for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to $244.9 million.

  • Cogent Biosciences' Current Assets rose 55.53% to $207.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $207.5 million, marking a year-over-year increase of 55.53%. This contributed to the annual value of $244.9 million for FY2020, which is 503.37% up from last year.
  • Cogent Biosciences' Current Assets amounted to $244.9 million in FY2020, which was up 503.37% from $40.6 million recorded in FY2019.
  • In the past 5 years, Cogent Biosciences' Current Assets ranged from a high of $244.9 million in FY2020 and a low of $40.6 million during FY2019.
  • Its 3-year average for Current Assets is $122.2 million, with a median of $81.0 million in 2018.
  • Per our database at Business Quant, Cogent Biosciences' Current Assets tumbled by 49.89% in 2019 and then spiked by 503.37% in 2020.
  • Yearly analysis of 4 years shows Cogent Biosciences' Current Assets stood at $42.4 million in 2017, then surged by 91.14% to $81.0 million in 2018, then plummeted by 49.89% to $40.6 million in 2019, then surged by 503.37% to $244.9 million in 2020.